CAR T cells: driving the road from the laboratory to the clinic.
about
Chimeric Antigen Receptors Modified T-Cells for Cancer TherapyNovel immunotherapies for hematologic malignanciesCD19-Chimeric Antigen Receptor T Cells for Treatment of Chronic Lymphocytic Leukaemia and Acute Lymphoblastic LeukaemiaT cell engineering as therapy for cancer and HIV: our synthetic futureGlycobiology of neuroblastoma: impact on tumor behavior, prognosis, and therapeutic strategies.Arginine deiminase expressed in vivo, driven by human telomerase reverse transcriptase promoter, displays high hepatoma targeting and oncolytic efficiency.Targeting CD8+ T-cell tolerance for cancer immunotherapy.Incorporation of a hinge domain improves the expansion of chimeric antigen receptor T cells.Current advances in T-cell-based cancer immunotherapyL1 Cell Adhesion Molecule-Specific Chimeric Antigen Receptor-Redirected Human T Cells Exhibit Specific and Efficient Antitumor Activity against Human Ovarian Cancer in MiceScreening and identification of human ZnT8-specific single-chain variable fragment (scFv) from type 1 diabetes phage display library.A role for multiple chimeric antigen receptor-expressing leukocytes in antigen-specific responses to cancer.Engineering T cells for cancer: our synthetic future.Allogeneic chimeric antigen receptor-modified cells for adoptive cell therapy of cancer.Translational research in oncology--10 years of progress and future prospects.Chimeric antigen receptor engineering: a right step in the evolution of adoptive cellular immunotherapy.Exploiting cytokines in adoptive T-cell therapy of cancer.Experimental Therapeutic Trial Design for Pediatric Brain Tumors.Chimeric antigen receptor-engineered natural killer and natural killer T cells for cancer immunotherapy.The basics of CAR T design and challenges in immunotherapy of solid tumors - Ovarian cancer as a model.Spotlight on chimeric antigen receptor engineered T cell research and clinical trials in China.Immunotherapy approaches to treat adult acute lymphoblastic leukemia.How Chimeric Antigen Receptor Design Affects Adoptive T Cell Therapy.Metabolic regulation of immune responses: therapeutic opportunities.Recombination-deletion between homologous cassettes in retrovirus is suppressed via a strategy of degenerate codon substitution.Chronic inflammation: is it the driver or is it paving the road for malignant transformation?CAR-T cell therapy in ovarian cancer: from the bench to the bedside.B cells for cancer immunotherapy.CD47-CAR-T Cells Effectively Kill Target Cancer Cells and Block Pancreatic Tumor Growth.CAR-T Cell Therapy: From the Bench to the Bedside.Methods and practices to diversify cell-based products.New Approaches in CAR-T Cell Immunotherapy for Breast Cancer.'Atypical' CAR T cells: NKG2D and Erb-B as examples of natural receptor/ligands to target recalcitrant solid tumors.T cell modulation in immunotherapy for hematological malignancies.CAR-T cells targeting CLL-1 as an approach to treat acute myeloid leukemia.The development of CAR design for tumor CAR-T cell therapy.EphA2 chimeric antigen receptor-modified T cells for the immunotherapy of esophageal squamous cell carcinoma.
P2860
Q26773309-E04D3F31-0DBA-478A-BF22-EACDF7D81F50Q27004436-FF38B07D-14EA-4FE5-9498-0B11E2D8D079Q28081600-754533D7-6E31-4D7B-8881-1742104B4FACQ28082253-C4043BA6-0B81-478F-AC80-C64159FA6E89Q33659849-786F16F5-6DCC-4F78-B7E4-EF2B5E1D6545Q33914097-0F4A39D1-3F79-4B61-B0CE-31DACDDFC213Q34432692-CBA00688-BC4D-4C1C-B9AD-431D3CE51633Q34553167-F0D2077D-BC24-46D2-8DB7-9FFE94F1554AQ35215158-C672535F-AFB1-42AB-B2A5-274AA8098E2CQ35892897-525A284C-F7A5-4F25-A86B-ED27DBD1A2FEQ36043179-1BA29F87-4B5F-4F86-B7A9-5FFF7002B521Q37376346-4C1559FE-BA23-4A20-A943-0A153C55CC75Q37515502-37EB769B-4738-4172-A2FA-741EE91E0F51Q38198742-686E6D39-2395-4E7C-9A96-7098F696AF4BQ38257126-29BD52C7-AFB9-4685-BAA6-F5128BDDAA15Q38435415-668E2AA3-C787-4A93-8DD7-EF1B871EEAC8Q38525044-D72ADF2A-EF6C-42FD-A0E3-0DA288ACC176Q38583655-B812897B-7977-4EDC-B022-185DD88E7AD8Q38666579-6EF5B747-0903-414D-A3BF-F6968F50C8D6Q38748836-56DFCBE8-B139-4196-93D0-4FDFFB00C137Q38786626-F9B0CF54-BCFE-4E1B-9281-0E45242A03E4Q38787405-A9D0A5D8-7030-44C7-B74A-97F629EBCD97Q38830813-870D96C4-759C-45BF-96FD-ED98C49819BAQ38850162-A9357F94-9391-4499-90DA-98DA038CB5ABQ41878298-39DE8197-04A2-41FF-8933-CAD49BB348FFQ42129388-1D8E53B6-3C33-4470-9521-2A984D50E03BQ42362802-79E4656C-51DC-4E38-A7EA-2933C8EA53D2Q42553558-408E52B1-3E88-4D0A-AA07-F64EC8E5FA97Q47121255-E9F76F6F-EB95-4340-AB6E-B2C706026855Q47121638-25567A5E-3B1E-45C3-B548-D2730CE9DFBBQ47246973-1915E7B6-2175-4ED1-9F0D-3DD3159A38E4Q47761448-694A453E-B36F-4E70-AD7D-83A7288A0680Q47849932-26417B3A-8394-446F-ABE4-25482EBDE3E1Q48188087-85BF17C9-7812-419F-9588-1F2B35ABC00CQ49168672-7426CB6D-9B63-4551-BDE7-4BCEFCAAC119Q52641562-5639F0FF-EF39-4F3A-8BC0-E656CFDE686CQ55689740-98F82D35-EB2F-4552-B739-1A69733B64E2
P2860
CAR T cells: driving the road from the laboratory to the clinic.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
CAR T cells: driving the road from the laboratory to the clinic.
@en
type
label
CAR T cells: driving the road from the laboratory to the clinic.
@en
prefLabel
CAR T cells: driving the road from the laboratory to the clinic.
@en
P2093
P2860
P356
P1476
CAR T cells: driving the road from the laboratory to the clinic
@en
P2093
Eleanor J Cheadle
Hannah Gornall
Robert E Hawkins
Vania Baldan
Vivien Hanson
P2860
P304
P356
10.1111/IMR.12126
P50
P577
2014-01-01T00:00:00Z